Cargando…
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
Thrombopoietin receptor agonists (TPO‐RAs) are used as effective alternative treatments in ITP patients unresponsive to first‐/second‐line therapies. TPO‐RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsiv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538052/ https://www.ncbi.nlm.nih.gov/pubmed/28781864 http://dx.doi.org/10.1002/ccr3.920 |